657 related articles for article (PubMed ID: 27632563)
1. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
[TBL] [Abstract][Full Text] [Related]
2. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
[TBL] [Abstract][Full Text] [Related]
3. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
4. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
6. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
[TBL] [Abstract][Full Text] [Related]
7. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
[TBL] [Abstract][Full Text] [Related]
8. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
[TBL] [Abstract][Full Text] [Related]
9. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
[TBL] [Abstract][Full Text] [Related]
10. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
[TBL] [Abstract][Full Text] [Related]
11. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
[TBL] [Abstract][Full Text] [Related]
12. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A
Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412
[TBL] [Abstract][Full Text] [Related]
15. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
16. Designing multivalent immunogens for alphavirus vaccine optimization.
Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
[TBL] [Abstract][Full Text] [Related]
17. Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.
Phelps AL; O'Brien LM; Ulaeto DO; Holtsberg FW; Liao GC; Douglas R; Aman MJ; Glass PJ; Moyer CL; Ennis J; Zeitlin L; Nagata LP; Hu WG
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835037
[TBL] [Abstract][Full Text] [Related]
18. Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.
Smith DR; Schmaljohn CS; Badger C; Ostrowski K; Zeng X; Grimes SD; Rayner JO
Antiviral Res; 2020 Oct; 182():104875. PubMed ID: 32755661
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Coates EE; Edupuganti S; Chen GL; Happe M; Strom L; Widge A; Florez MB; Cox JH; Gordon I; Plummer S; Ola A; Yamshchikov G; Andrews C; Curate-Ingram S; Morgan P; Nagar S; Collins MH; Bray A; Nguyen T; Stein J; Case CL; Kaltovich F; Wycuff D; Liang CJ; Carlton K; Vazquez S; Mascola JR; Ledgerwood JE;
Lancet Infect Dis; 2022 Aug; 22(8):1210-1220. PubMed ID: 35568049
[TBL] [Abstract][Full Text] [Related]
20. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
